Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

NCT05467176 is registered in ClinicalTrials.gov with Sumitomo Pharma America, Inc. as lead sponsor.

NCT NCT05467176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05467176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
Lead sponsor
Sumitomo Pharma America, Inc.
Phase
Observational
Overall status
Completed
Start date
October 4, 2022
Completion date
June 30, 2026
Enrollment
999 (actual)
Sites
96

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer